Internal Medicine, Hematology & Oncology · Youngstown, OH
NPI
1336190701
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
835 Southwestern Run
Youngstown, OH, 44514
Phone (330) 318-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
200,481 services
Medicare patients, 2024
599
Average age 75
Drug cost, 2024
$7.2M
2,995 prescriptions
Company payments, 2025
$3,044
From 47 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy B Awaida was code J1439 (injection, ferric carboxymaltose, 1 mg), 50,251 times for 29 patients. In total Amy B Awaida billed 200,481 services in 103 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 50,251 | 29 | $0.86 | $43K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 23,850 | 11 | $2.31 | $55K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 19,000 | 11 | $0.06 | $1,049 |
| J0185 Injection, aprepitant, 1 mg | Office | 13,650 | 24 | $1.33 | $18K |
| J0897 Injection, denosumab, 1 mg | Office | 6,300 | 25 | $19.69 | $124K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,540 | 38 | $0.09 | $228 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,290 | 16 | $0.24 | $312 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,150 | 25 | $0.70 | $802 |
| 96367 Intravenous Infusion, Hydration | Office | 524 | 45 | $20.01 | $10K |
| 99214 Office E&M - Established | Office | 517 | 286 | $89.83 | $46K |
| 99213 Office E&M - Established | Office | 470 | 354 | $61.91 | $29K |
| 96375 Injection Administration | Office | 346 | 46 | $10.99 | $3,802 |
| 96413 Chemotherapy Administration | Office | 345 | 42 | $92.83 | $32K |
| 96372 Injection Administration | Office | 289 | 52 | $10.27 | $2,969 |
| 99215 Office E&M - Established | Office | 233 | 82 | $133.39 | $31K |
By year: 2022 $2.5M for 165,632 services; 2023 $3.4M for 187,015 services; 2024 $2.4M for 200,481 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy B Awaida prescribed most often to Medicare patients was Anastrozole, with 682 prescriptions and refills. In total Amy B Awaida wrote 2,995 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 682 | 1,818 | 193 | $11K |
| Ondansetron Hcl Generic | 127 | 127 | 46 | $13K |
| Ondansetron Odt Ondansetron | 92 | 92 | 47 | $1,745 |
| Hydroxyurea Generic | 90 | 193 | 28 | $1,615 |
| Neulasta Onpro Pegfilgrastim | 80 | 80 | 20 | $502K |
| Exemestane Generic | 64 | 98 | Under 11 | $7,790 |
| Letrozole Generic | 56 | 120 | 18 | $986 |
| Prednisone Generic | 56 | 58 | 30 | $109 |
| Ibrance Palbociclib | 55 | 55 | Under 11 | $877K |
| Dexamethasone Generic | 51 | 55 | 26 | $917 |
| Prochlorperazine Maleate Generic | 46 | 48 | 12 | $415 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 44 | 44 | 16 | $630 |
| Gabapentin Generic | 42 | 76 | 16 | $512 |
| Aranesp Darbepoetin Alfa In Polysorbat | 41 | 41 | Under 11 | $67K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 41 | 41 | 20 | $1,036 |
Brand drugs: 670 claims; generic drugs: 2,325 claims; opioid claims: 124.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy B Awaida $3,044 ($3,044 in general payments such as food, travel and fees) from 47 companies. The largest payer was Novartis Pharmaceuticals Corporation with $253.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 13 | $253 |
| Pfizer Inc. PFE | 14 | $247 |
| Merck Sharp & Dohme LLC MRK | 9 | $208 |
| Daiichi Sankyo Inc. 4568.T | 10 | $207 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $181 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $168 |
| Eisai Inc. 4523.T | 4 | $113 |
| TerSera Therapeutics LLC | 4 | $103 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $87.85 |
| ASD Specialty Healthcare, LLC | 1 | $81.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.